SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-23-064858
Filing Date
2023-11-17
Accepted
2023-11-17 16:33:24
Documents
1
Period of Report
2023-11-15

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 23846
  Complete submission text file 0000950170-23-064858.txt   25966
Mailing Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158 415-865-2050
COLUMN GROUP L P (Reporting) CIK: 0001347769 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38853 | Film No.: 231419295

Mailing Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-243-5555
NGM BIOPHARMACEUTICALS INC (Issuer) CIK: 0001426332 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 LETTERMAN DRIVE, BUILDING D SUITE DM-900 SAN FRANCISCO CA 94129
Business Address 1 LETTERMAN DRIVE, BUILDING D SUITE DM-900 SAN FRANCISCO CA 94129 415-865-2050
TCG Opportunity III GP, LLC (Reporting) CIK: 0001932445 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38853 | Film No.: 231419294